Claire M. Wagner: Inaugural Boston Biotech Investor Day brought together more than 70 investment funds
Claire M. Wagner shared on LinkedIn:
“Inaugural Boston Biotech Investor Day brought together more than 70 investment funds and more than 40 startups taking big bets on cutting edge ideas and technology. Super energizing event.
It was a pleasure to speak about global health access terms and nondilutive capital to maximize future public health potential, and how we think about market access at the Bill and Melinda Gates Medical Research Institute.
Thank you Adam Jenkins and BioLabs team for convening this event and creating opportunities for innovation and impact.”
Source: Claire M. Wagner/LinkedIn
Dr. Claire M. Wagner is the Head of Corporate Strategy & Market Access at the Bill and Melinda Gates Medical Research Institute, where she leads the institute’s global access strategy across its portfolio and oversees engagement with commercial partners, financial institutions, and multilateral organizations. She is also an Associate Scientist in Medicine at the Division of Global Health Equity at Brigham and Women’s Hospital.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023